D. Western Therapeutics Institute Inc
6DW
Company Profile
Business description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Contact
7th Floor, 18 KT Bulding
1-18-11, Nishiki, Naka-ku
Aichi
Nagoyashi460-0003
JPNT: +81 52218785
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
21
Stocks News & Analysis
stocks
AMD earnings: Data center demand still looks quite strong to us
AMD has the components to target $100 billion of AI revenue in the next few years.
stocks
PayPal earnings: Growth slows, new CEO appointed
We expect to lower our fair value estimate of PayPal stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,154.90 | 26.00 | -0.28% |
| CAC 40 | 8,262.16 | 82.66 | 1.01% |
| DAX 40 | 24,603.04 | 177.75 | -0.72% |
| Dow JONES (US) | 49,501.30 | 260.31 | 0.53% |
| FTSE 100 | 10,402.34 | 87.75 | 0.85% |
| HKSE | 26,667.56 | 179.76 | -0.67% |
| NASDAQ | 22,904.58 | 350.61 | -1.51% |
| Nikkei 225 | 53,872.78 | 420.58 | -0.77% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,882.72 | 35.09 | -0.51% |
| S&P/ASX 200 | 8,889.20 | 14.80 | -0.17% |
| SSE Composite Index | 4,076.35 | 25.85 | -0.63% |